An Immune–Magnetophoretic Device for the Selective and Precise Enrichment of Circulating Tumor Cells from Whole Blood

Here, we validated the clinical utility of our previously developed microfluidic device, GenoCTC, which is based on bottom magnetophoresis, for the isolation of circulating tumor cells (CTCs) from patient whole blood. GenoCTC allowed 90% purity, 77% separation rate, and 80% recovery of circulating t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chelakkot, Chaithanya, Ryu, Jiyeon, Kim, Mi Young, Kim, Jin-Soo, Kim, Dohyeong, Hwang, Juhyun, Park, Sung Hoon, Ko, Seok Bum, Park, Jeong Won, Jung, Moon Youn, Kim, Ryong Nam, Song, Kyoung, Kim, Yu Jin, Choi, Yoon-La, Lee, Hun Seok, Shin, Young Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345362/
https://www.ncbi.nlm.nih.gov/pubmed/32486306
http://dx.doi.org/10.3390/mi11060560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345362/
https://www.ncbi.nlm.nih.gov/pubmed/32486306
http://dx.doi.org/10.3390/mi11060560

Ejemplares similares